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Affinity chromatography on Bowittgitt trtifdbrurdii ngglutinin (BMA) Sepharose of glycopeptides confirmed a previous report using oligo- 
saccharides (Animashaun, T. and Hughes, RC. (1989) J. Biol, Chem. 264.46574663) that high affinity binding rcquircs the sequence Manal 42 
Manal- Manol-tb Manpl44. However, moderate binding was still exhibited by structures lacking this sequence provided the oligosaccharidc 
core sequence Manal ~3[Manal+G]Man/3l~4GlcNAc was present. This moderate binding was not affected by substitution with N-acetylgluco- 
saminc at C2 and C4, respectively, of the Manor143 and Mar@1+4 residues and BMA Sepharosc should prove to be a useful tool for the isolation 
of bisected or non-bisected hybrid-type glycans. 
Bowritrgia tttildbraedii agglutinin; Pectin; Carbohydrate binding specificity 
I. INTRODUCTION 
Previously we described a novel lectin isolated from 
a Nigerian legume Bowringia mildbraedii Harms [I]. 
The lectin, Bowritgia rrliidbraedii agglutinin or BMA, 
was shown to differ significantly in carbohydrate-bind- 
ing specificity from other well-known lectins of le- 
guminous plants such as Concanavalin A (Con A). Oli- 
gosaccharides bearing the sequence Manal 
Manal+ Manal+ Man, for example Man,GlcNAc 
and certain structural isomers of Man,GlcNAc and 
Man,GlcNAc released from glycoproteins with endo- 
glycosidase H, interacted with BMA more avidly than 
other Man,GlcNAc and Man,GlcNAc isomers. More 
highly processed structures uch as Man,GlcNAc and 
ManSGlcNAc were shown to bind relatively weakly. 
Thus, BMA binds preferentially to glycans present in 
glycoproteins subjected to early steps of oligosaccharide 
processing in the endoplasmic reticulum and less so to 
those exposed to more extensive processing by Golgi 
mannosidases [2], making BMA a useful histochemical 
marker for the endoplasmic reticulum [I]. 
of oligomannosidic glycopeptides as well as endo H- 
released oligosaccharides. The binding of complex- and 




BMA was purified from Bon~rit@u tttifdbraedii seeds by aflinity 
chromatography on p-aminophcnyls-o-mannopyranosidc-agarose 
[I]. BMA Sepharose was prepared as described [I] and Con A 
Sepharosc was from Pharmacia/tKB, Milton Keynes, UK. 2- 
[“H]Mannose (13.4 Ci/mmol), [L-5.6.‘H]fucose (45 Ci/mmol) and 
[I-“C]acetic anhydride (32 Ci/mmol) were from Amersham lnternn- 
tional, UK. Sodium boro [‘HIhydride (600 Ctimmol) was from NEN 
DuPont. Endoglycosidases-H (endo H) and -D (endo D) were from 
Boehringer-Mannheim, Arllrrobucter ureuficietts sialidase was from 
Nacalai Tesquc, Kyoto, Japan, Other reagents wcrc from Sigma Carp, 
We have now examined further the carbohydrate- 
binding specificity of BMA using glycopeptide and oli- 
gosaccharide standards. The results confirm and extend 
the previously reported [I] specificity for oligomanno- 
sidic structures and show that afiinity chromatography 
on BMA Sepharose is a useful tool for the separation 
Abbreviuficm: BMA, Bowrittyiu rrri~dhuedii agglutinin; Con A, Con- 
car,avalin A; endo H, endoglycosidase H; endo D, endoglycosidase D; 
GIcNAcoT, N-acetylglucosaminitol. 
Cur~~e~/Jti&rlcr ~ t&es’s: R.C. Hughes, National Institute for Medical 
Research, The Ridgeway, Mill Hill, London NW7 IAA, UK. Fax: 
(44) (81) 906 4477. 
Oligosaccharide 1 (Table 1) was prepared from BHK cells, mc- 
tabolically labelled for 2 days with [‘Hjmannose, as described [3]. 
Briefly, the glycopsptides obtained from labellcd cells by pronasc 
digestion were fraclionated on Con A Sepharose, the oligomannosidic 
glycopeplidcs elutcd with 200 mM methyl-or-mannoside were treated 
with endo H and the released oligosaccharides were separated by 
paper chromatography. Oligosaccharidc 2 was prepared from the bi- 
antcnnary glycan released from human serum transfcrrin [4] by hydrd- 
zinolysis followed by exhaustive digestion with ~rrltro~ticrrr mu- 
facietrs sialidase followed by jack beanD galactosidase andp N-acetyl- 
glucosaminidase. This and other oligosaccharides, a  indicated, were 
labelled by reduction with NaB3Ha [I]. Glycopcptides 3and 4 xvcre 
obtained from [‘Hlmannose- or [‘Hlfucosc-labclled ricin-resistant 
Ri&l cells as describe d [S]. Oligosaccharides 5, 6 and 7 were ob- 
tained from swainsonine-treated BHK cells, mclilbolically labellcd 
with [‘Hlmannose for 2 days, by sequential chromatography of glyco- 
peptides on Con A Sepharose, lentil lectin Sepharose and DEAE 
Sephacel columns followed by endo H digestion, cxo-glycosidase 
treatments and Bio-Gcl P-4 chromatogritphy x des;riScd f6.q. C!~CO- 
peptides 8 and 9 and oligosaccharidcs 16 and 17 wcrc gifts from G. 
Streckcr (Universitc des Sciences et Techniques, Lille, France). The 
Published by Elsevter Sciettre Publisftcrs B. V. 291 
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giycopeptides were labelled by treatment with [i-t"C]acetic anhydride 
[5]. The remaining compounds were gifts from S, Sate (NIMR, 
London) and were prepared and labelled as described [8]. 
2,3. Pulse.ch.se tube~ling 
Ricin.resistant Ricnl4 cells [9,10] were grown at 37°C in 6 cm 
diameter dishes as monolayers in Eagle's medium supplemented with 
10% foetal calf serum, Nearly confluent monolayers were rinsed twice 
with Eagle's medium containing 2 mM (one tenth) of the usual con- 
centration of glucose and 10% dialysed serum and incubated lbr 30 
rain with the same medium (2 ml) containing 1 mCi ['~l-l]mannose. 
After labelling, the monolayers were rinsed twice with Eagle's medium 
containing the normal amount of glucose plus 5 mM t~on-radioactiv¢ 
mannose and chased at 37"C for 4 h, The cells were harvested, lipid 
extracted and a glycopeptide traction was obtained by pronase diges- 
tion of cellular glycoproteins a described [1 II, Briefly, defatted cell 
residues were suspended in 50 mM Tris-HCl, pH 7,5, 20 mM CaCI:, 
heated at 90°C for 5 rain and then treated with 100/zl of pronase (0.4% 
in the above buffer) at 370C for 2 days, The digests were re-heated and 
the glycopeptides were i~olated by Bio-Ciel P-2 chromatography, 
2,4. Endo gl),cosidase digests 
Glycopeptides dissolved in 0.2 M sodium acetate buffer, pH 6, (20 
#1) wer~ treated with ¢ndo H (2,5/~1, 2 5 mU) plus endo D (2.5/~1, 2.5 
mU) at 37°C for 1-2 days, After incubation the digests were heated 
at 90°C l'or 5 rain. 
2,5. Cl~ramatography 
Radioactively labelled glycopeptid¢ or oligosaceharid¢ samples (ap- 
proximately 1-2 x 10 ~ counts/rain) were applied in 1 ml of elution 
buffer 10 mM Tris-HCl, pH 7,5, 150 mM NaCl, 1 mM MgCl:, 1 mM 
CaCh to columns (1,5 hal) of BMA Sepharosc or Con A Sepharose 
equilibrated with elation buffer at room temperature, After incubation 
for 1 h at room temperature the columns were washed sequentially 
with elation buffer (9 ml) and 10 ml each of 10 mM methyl-r,-glu. 
coside, I0 raM methyl-et.mannoside and 200 mM metbyl.e,.man. 
noside in elution buffer, Fractions (1 ml) were collected and counted 
for radioactivity, Paper chromatography of oligosaccharides was per- 
formed on Whatman I Chr paper using ethyl ac¢tat~/pyridine/acetic 
acid/water (5:5:1:3, by volume) as solvent. Following development for 
3-5 days the dried paper was cut into 1 cm segments: each segment 
was elated with 1 ml of water and eluates were counted for radioac- 
tivity. 
3. RESULTS AND DISCUSSION 
3.7. Interactions of BMA with o/igomannosidic glyco. 
peptides 
The fact that BMA appears to be a marker for the 
endoplasmic reticulum [1], expected to be rich in poorly 
processed oligomannosidic structures [2], suggested that 
the unique binding specificity of BMA established using 
endo H-released oligosaccharides [7] could be extended 
to peptide-linked glycans. Results (Fig. 1) of affinity 
chromatography on BMA Sepharose of a glycopeptide 
mixture obtained from the ricin-resistant RicRI4 cell 
line, deficient in GIcNAe transferase I and unable to 
convert oligomannosidic structures into complex- or 
hybrid-type glycans [9,10], supported this supposition. 
Glycopeptides generated from [3H]mannose-labelled 
cells were treated with endo H and endo D and the 
released oligosaccharides were analyzed by paper 
chromatography. The major products were 
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Fig. 1. Fractionation of oligomannosidic glycopeptides on BMA 
Sepharose, CA) A glycopeptid¢ mixture obtained from [3H]mannose- 
labelled Rical4 cells by pronase digestion (15 × 104 counts/min) was 
applied to BMA Sepharose, Fractions (1 ml) were elated with buffer, 
10 mM methyl-~-glucosid¢ (a),10 mM methyl-ct.mannoside (b) and 
200 mM methyl-~-mannoside (c), (B-D) Paper chromatography of 
¢ndo H digests of total glycopept:,de~ (B) and 81yeopeptides lated 
from BMA Sepharose with 10 mM methyl-,,-glu~side (C) or 200 mM 
methyl-~t-mannoside (D),After chromatography using approximately 
5 × 10 ~ counts/rain, the paper strips were cut into 1 cm segments, eluted 
with water and counted for radioactivity. The migration of standard 
oligosaceharides is indicated: (9) MangGIcNAe; (8) Man~OlcNAe; (7) 
ManTGIeNAc; (6) ManoGIcNAc; (5) Mnn~GIcNAe, 
equal amounts of Man6GlcNAc, ManTGIcNAc and 
ManaGlcNAc (Fig. 1B). When the glycopeptide mixture 
was subject ed to affinity chromatography on BMA 
Sepharose, major fractions were eluted with 10 mM 
methyl-~-glucoside and with 200 mM methyl-~-man- 
noside (Fig. IA). Each glycopeptide fraction was 
treated with endo H and endo D and analyzed by paper 
chromatography. The material eluted with 10 mM 
methyl-=-glucoside contained over 90% of the 
Man~GIeNAc and Man6GlcNAc with a minor peak of 
Man~GlcNAc and no detectable MansGlcNAc or 
MangGIcNAc (Fig. 1C). This material eluted with 200 
mM methyl-0t-mannoside contained all of the 
MangGIcNAc and ManaGIcNAc, about 70% of the 
ManTGIcNAc and only trace amounts of Man6OlcNAc 
and Man~GIcNAc (Fig. 1D). 
3.2. Interactions with complex- and hybrid-type glycans 
Eighteen oligosaccharides or glycopeptides of known 
structures (Table 1) were analysed by BMA Sepharos¢ 
affinity chromatography under standard conditions 
given in section 2. Representative elution profiles are 
shown in Fig. 2 and all of the results are collected in 
Table 7. In the following discussion w.- refer to mo- 
derate, and high-affinity binding in relation to oligosac- 
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Fig. 2. Aflinity chromatography of complex- and hybrid-type oligo- 
saccharides on BMA Scpharosc. Samples (approximately 10” counts/ 
min) were applied in I ml of elution buffer to columns (1 ml) of BMA 
Sepharase and fractions (I ml) were cluted with elution buffer fol- 
lowed by 10 mM methyl-a-glucoside (a) and 10 mh4 methyl-a-man- 
noside (b) in elution buffer. No additional radioactivity was cluted 
with 200 mM methyl-z-mannoside. (A) Compound 18; (B) compound 
14; (CJ compound 9. (D) compound 8; (E) compound 2. See Table I 
for structures. 
charides or glycopeptides eluted from lectin columns 
with 10 mM and 200 mM sugar, respectively. Oligosac- 
charides howing no affinity are eluted in the void vol- 
ume with buffer and weak-affinity binding is indicated 
by a retarded elution with buffer. 
High affinity binding to Con A requires only two 
appropriately placed, non-reducing mannose residues 
[12,13], as are present on the outer branches of com- 
pounds 1 and 2 (Table 1), and the Manal- 
Manal- Manal+ sequence recognised by BMA 
(Fig. 1 and [l]) is not an essential requirement. Con- 
versely, two non-reducing mannose termini are not by 
themselves sufficient for high affinity binding to BMA, 
since compounds 1 and 2 were eluted from BMA 
Sepharose with 10 mM sugar (Table 1). However, we 
showed previously [l] that a straight-chain compound 
Manal+ ManPl+4GlcNAc bound weakly to BMA 
Sepharose and was eluted with buffer alone, showing 
that two interacting mannose units do increase the affin- 
ity of glycans for BMA as they do for Con A [123. In 
the case of Con A, substitution of the interacting 
mannose residues at C2 may weaken but does not 
abolish binding [ 12,133 and compound 3 (Table 1) binds 
with high affinity. Similarly, with BMA, substitution of 
the Mancxl+3 unit at C2 in compound 3 (Table 1) had 
only a small weakening effect on recognition of the core 
pentasaccharide, compound 2 (Table 1). However, sub- 
stitution at C2 and C4, as in compound 4 (Table 1), 
completely abolished binding to BMA, as it does for 
high affinity Con A binding [S]. By contrast, the Mans- 
hybrid structures 5 and 7 (Table 1) bound to similar 
extents to BMA Sepharose presumably due to the pres- 
ence in both compounds of two non-reducing mannose 
residues in the outer branches. Similarly, Con A hinds 
with high affinity to both these compounds [6,14]. Inter- 
estingly, shortening of the antennae on the Manal+ 
residue of the core, and exposure of a non-reducing 
GlcNAc residue (compound 6, Table 1) appeared to 
increase interactions with BMA Sepharose. 
BMA retains interactions with bisected hybrid-type 
compounds during affinity chromatography as shown 
by similar chromatographic behaviours of compounds 
6 and 8, and compounds 7 and 9, respectively (Table l). 
Attachment of a bisecting GlcNAcj31+4 residue to the 
p-linked mannose is believed to restrict the rotational 
flexibility of the al+6 linked mannose unit [15] and 
appears to hinder adoption of a conformation suitable 
for high affinity binding to Con A [12,13,16]. Evidently 
the orientation of the orI+ linked mannose relative to 
the CS-C6 bond of the core B-linked mannose, espe- 
cially in monoan;ennary hybrid-type compounds, plays 
a less important role in binding to BMA than it does to 
Con A, or the two lectins recognize different conforma- 
tional variants of this structure. 
As is the case for affinity chromatography on Con A 
Sepharose [12], substitution of both a-linked mannose 
residues of the core pentasaccharide at C2, as in 
biantennary complex-type structures IO-12 (Table l), 
weakened binding to BMA Sepharose but did not 
abolish it and the compounds were eluted by buffer in 
a retarded position (Table I, Fig. 2). In agreement with 
the results obtained for hybrid-type compounds dis- 
cussed above, exposure of a terminal GlcNAc residue 
in compound 13 increased significantly the binding of 
a biantennary glycan as shown by the more retarded 
elution position of compound 13 compared with the 
fully galactosylated erivatives 10-12. A similar be- 
haviour has been demonstrated for Con A binding [17]. 
The biantennary compound 14, containing 
Gal,81+3GlcNAc termini, behaved similarly on BMA 
Sepharose as compounds 10-12 with a 
Galj31+4GlcNAc termina! sequence. The behaviour on 
BMA Sepharose of tri- and tetre-antennary glycans, 
compounds 15-18 showed (Table 1, Fig. 2) that all of 
these structures are unretarded as they are on Con A 
Sepharose [ 121. 
In conclusion, the present data extend knowledge of 
the carbohydrate binding specificity of BMA. The over- 
all similarities in binding specificities suggest that BMA 
shares a common evolutionary origin with Con A and 
probably other legume lectins. However, BMA clearly 
shows some unique binding properties and represents a 
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Structure of ol{gosaccharides and g[ycopeptides and their 
elution profiles on BMA Sepharose 
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1 
Sample Structure Elutlcn Profile 
Man,-. 
1~6 
1 E Man,'. 1,,.. 3 M,~n a 1 ... S 
Manet 1 " 3Man [3 
1-4GIcNA¢ 
2 Manet 1-.8 
Man o¢ 1 " 3 Man [3 1- 4GtcNA¢ ~ 1- 4GIcNAc OT E 
Fuc ¢1 
Man = 1 "- 6 Man ~ 1- 4GIoNAc ~ 1- 4G.=NAc-Asn 
NeuNA¢ ¢¢ 2 - 3 Gall31-4GIcNA¢ ~ 1-2Man c¢ 1 -" 3 
D 
4 
Fuc ¢z 1 
Gal [3 1- 4GIcNA¢ [31 • 4 Man ~ t ~ 6 Man 131- 4GIcNA¢ [3 1- =IG~NAc- Ash 
' "2Man ct 1.--3 
Gall3 1- 4GIcNA¢[31,' 
A 
Man a 1 , ,6  
Manet 1 ,' 3Man ¢x 1,,, 6 
Ga113 1-4GIcNAc,~l--2Man ot 1 -'3 Man[3 1-4GIcNAc 
C 
Man ct 1., 6 
3Man 1 G 
Man ¢¢ lP ~'~ Man [3 1- 4GlcNAc 
G]¢NA¢ [31-2Mano: 1 
D 
7 
Mano¢ 1,,. 6 
Manet 1 s3Man ¢~ 1~ 6 
Gal [J, 1- 4GIcNAc [31.~ 4 Man o~ 1 / 3 Man j5 1- 4GIcNA¢ 
Gal~ "t- 4GIcNAc[3 't" 2 
Man ¢¢ 1 
Man ,-,, 1,,. 3 
GI¢NA~ [~ 1- 2 
GIcNA¢ ~ 1 
4 
Man (x 1 .,. 6 Mm, n ~ 1- 4GImNA: ~ 1 - 4GIcNAc-Asn 




Man a 1 6 GIcNA¢ ~ 1 
Man c~ 1,* 3 Man (~ 1 4 
6 M,~n [31-4GIcNA¢ i3 I-4GIcNAc-Asn /3 
GIcNA¢ [31.,. 4 Manc~l ' 
Gk:NAc ~ 1," 2 
C 
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10 Gal I~ 1-4GIcNAc 15 1-2Man a 1 -,.. 6 Man 13 1- 4GIcNAc 15 1- 4GIcNAe-Asn 
Gall5 1-4GleNA= 15 1-2Man ot 1,,'3 
B 
11 Ga115 1-4GIcNAc 15 1-2Man ¢z 1-.. 6 Man15 1-4GIeNA¢ 15 1-4GIcNA¢ OT 
Gall3 1-4GI¢NA¢I]. 1-2Man ct 1 '..3 B 
12 
Ga115 1 - 4GIcNAc 15 1 - 2Man ¢t 1 .-. 6 Man ~ 1- 4GIcNA¢ 
Gall3 1-4GICNAc15 1-2Man ~ 1.-'3 OT B 
13 
GIcNAc P 1-2Man ct 
11: ~ Man[3 1-4GIeNA= OT 
Gall5 1-4GIcNA¢ [3 1-2Man ct C 
14 Gal [3 1- 3GIcNA¢ [3 1-2Man ot 1 .., 6 Man p 1- 4GleNAc 13 1- 4GIcNA¢ 
Ga113 1- 3GIcNA¢ I]' 1-2Man at 1 -- 3 GT 
B 
15 
Gal [~ 1- 4GIcNAe 131-2 Man cx 1 .,,. 6 
Gal ~ 1- 4GIoNA¢ l] '34 13 1- 4GleNA¢ [3 1-4GtcNA¢ OT 
Gal[~ 1-4GIcNA~I  ~'2 Man a 1 .,'3 Man 
A 
16 
Gall5 1- 4GIcNAc ~l-~'Man Q 1~ 
Ga115"1- 4GIeN'a'= 1:~4 Man 1,,, 6Man 13 1- 4GleNAeoT 
Gall3 1- 4GIcNA¢I31 ,'2 ¢t 
A 
17 
Ga115.1- 4GI¢NA¢ ~1 ~. 6 Man ct 1,. 
Gall3 1- 4GIcNAe 151 ," 2 6 Man [3 1-- 4Gk:NAc 
Ga113 1- 4GI¢NAc ~1-2  Man ¢t 1 -* OT 
A 
18 
Ga115,1- 4GIcNA¢ [31 ~ 6 
Gall5 1- 4GIeNAc151p2 Man ¢t 1,~ 6 Man 15 1-- 4GIcNA¢ 15 1- 4GIcNAc OT 
GaI15.1-4GIcNAc 151 ."4 Man ct 1 /3  
Gall5 1- 4GIcNAc131"2 
A 
1 Seefi 9. 2 
new and useful member of this family for the separation 
and analysis of glycan structures. 
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